Mutations affecting the sensitivity of the influenza virus neuraminidase to 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid

Virology

Volumn 238, Issue 2, 1997, Pages 265-272

  Goto, Hideo ^a   Bethell, Richard C ^b   Kawaoka, Yoshihiro ^a,c  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; GUANIDINE DERIVATIVE; N ACETYLNEURAMINIC ACID DERIVATIVE; VIRUS HEMAGGLUTININ; VIRUS SIALIDASE;

AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; DRUG RESISTANCE; DRUG SENSITIVITY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME MODIFICATION; ENZYME SUBSTRATE COMPLEX; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLUENZA VIRUS; MUTATION; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS;

EID: 0031585559     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8810     Document Type: Article

References (39)

1. Air G. M., Laver W. G. The neuraminidase of the influenza virus. Proteins Sturct. Funct. Genet. 6:1986;341-356.
2. Air G. M., Ritchie L. R., Laver W. G., Colman P. M. Gene and protein sequence of an influenza neuraminidase with hemagglutinin activity. Virology. 145:1985;117-122.
3. Baker A. T., Varghese J. N., Laver W. G., Colman P. M. Three-dimensional structure of neuraminidase of subtype N9 from an avian influenza virus. Proteins. 2:1987;111-117.
4. Bean W. J., Sriram G., Webster R. G. Electrophoretic analysis of lodine-labeled influenza virus RNA segments. Anal. Biochem. 102:1980;228-232.
5. Blick T. J., Tiong T., Sahasrabudhe A., Varghese J. N., Colman P. M., Hart G. J., Bethell R. C., Mckimm-Breschkin J. L. Generation and characterization of an influenza virus neuraminidase variant with decreased sensitivity to the neuraminidase-specific inhibitor 4-guanidino-Neu5Ac2en. Virology. 214:1995;475-484.
6. Bos T. J., Nayak D. J. Identification of defects in the neuraminidase gene of four temperature-sensitive mutants of A/WSN/33 influenza virus. Virology. 154:1986;85-96.
7. Bossart-Whitaker P., Carson M., Babu Y. S., Smith C. D., Laver W. G., Air G. M. Three-dimensional structure of influenza A N9 neuraminidase and its complex with the inhibitor 2-deoxy-2,3-dehydro-N. J. Mol. Biol. 232:1993;1069-1083.
8. Collins D. W., Jukes T. H. Rates of transition and transversion in coding sequences since the human-rodent divergence. Genomics. 20:1994;386-396.
9. Colman P. M. Neuraminidase: Enzyme and antigen. The Influenza Viruses. 1989;Plenum, New York. p. 175-218.
10. Colman P. M., Varghese J. N., Laver W. G. Structure of the catalytic and antigenic sites in influenza virus neuraminidase. Nature (London). 303:1983;41-44.
11. DuBridge R. B., Tang P., Hsia H. C., Leong P.-M., Miller J. H., Calos M. P. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol. Cell Biol. 6:1987;379-387.
12. Fields S., Winter G., Brownlee G. G. Structure of the neuraminidase gene in human influenza virus A/PR/8/34. Nature. 290:1981;213-217.
13. Gubareva L. V., Penn C. R., Webster R. G. Inhibition of replication of avian influenza viruses by the neuraminidase inhibitor 4-guanidino-2,4-dideoxy-2,3-dehydro-N. Virology. 212:1995;323-330.
14. Gubareva L. V., Bethell R., Hart G. J., Murti K. G., Penn C. R., Webster R. G. Characterization of mutants of influenza A selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en. J. Virol. 70:1996;1818-1827.
15. Hayden F. G., Treanor J. J., Betts R. F., Lobo M., Esinhart J. D., Hussey E. K. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza. JAMA. 275:1996;295-299.
16. Hayden F. G., Lobo M., Hussey E. K., Eason C. U. Brown L. E., Hampson A. W., Webster R. G. Options for the Control of Influenza III. 1996;718-725 Elsevier, Amsterdam.
17. Hiti A. L., Nayak D. P. Complete nucleotide sequence of the neuraminidase gene of human influenza virus A/WSN/33. J. Virol. 41:1982;730-734.
18. Lentz M. R., Air G. M. Loss of enzyme activity in a site-directed mutant of influenza neuraminidase compared to expressed wild-type protein. Virology. 148:1986;74-83.
19. Lentz M. R., Webster R. G., Air G. M. Site-directed mutation of the active site of influenza neuraminidase and implications for the catalytic mechanism. Biochemistry. 26:1987;5351-5358.
20. Matsumoto K., Nerome K., Numasaki Y., Oguri K., Fukuda T. Brown L. E., Hampson A. W., Webster R. G. Options for the Control of Influenza III. 1996;713-717 Elsevier, Amsterdam.
21. Mckimm-Breschkin J. L., Blick T. J., Sahasrabudhe A., Tiong T., Marshall D., Hart G. J., Bethell R. C., Penn C. R. Generation and characterization of variants of NWS/G70C influenza virus after in vitro passage in 4-amino-Neu5Ac2en and 4-guanidino-Neu5Ac2en. Antimicrob. Agents Chemother. 40:1996;40-46.
22. Mckimm-Breschkin J. L., Macdonald M., Blick T. J., Colman P. M. Mutation in the influenza virus neuraminidase gene resulting in decreased sensitivity to the neuraminidase inhibitor 4-guanidino-Neu5Ac2en leads to instability of the enzyme. Virology. 225:1996;240-242.
23. Meindl P., Bodo G., Palese P., Schulman J., Tuppy H. Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N. Virology. 58:1974;457-463.
24. Mitnaul L. J., Castrucci M. R., Murti K. G., Kawaoka Y. The cytoplasmic tail of influenza A virus neuraminidase (NA) affects NA incorporation into virions, virion morphology and virulence in mice, but is not essential for virus replication. J. Virol. 70:1996;873-879.
25. Niwa H., Yamamura K., Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene. 108:1991;193-200.
26. Palese P., Schulman J. L. Inhibitors of viral neuraminidase as potential antiviral drugs. Oxford J. S. Chemoprophylaxis and Virus Infections of Respiratory Tract. 1977;189-205 CRC Press, Cleveland.
27. Palese P., Tobita K., Ueda M., Compans R. W. Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology. 61:1974;397-410.
28. Prickett K. S., Amberg D. C., Hopp T. P. A calcium-dependent antibody for identification and purification of recombinant proteins. BioTechniques. 7:1989;580-589.
29. Reed L. J., Muench H. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 27:1938;493-497.
30. Ryan D. M., Ticehurst J., Dempsey M. H. GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-N. Antimicrob. Agents Chemother. 39:1995;2583-2584.
31. Ryan D. M., Ticehurst J., Dempsey M. H., Penn C. R. Inhibition of influenza virus replication in mice by GG167 (4-guanidino-2, 4-dideoxy-2,3-dehydro-N. Antimicrob. Agents Chemother. 38:1994;2270-2275.
32. Saiki R. K., Gelfand D. H., Stoffel S., Scharf S. J., Higuchi R., Horn G. T., Mullis K. B., Erlich H. A. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 239:1988;487-491.
33. Saito T., Kawaoka Y., Webster R. G. Phylogenetic analysis of the N8 neuraminidase gene of the influenza A viruses. Virology. 193:1993;868-876.
34. Staschke K. A., Colacino J. M., Baxter A. J., Air G. M., Bansal A., Hornback W. J., Munroe J. E., Laver W. G. Molecular basis for the resistance of influenza viruses to 4-guanidino-Neu5Ac2en. Virology. 214:1995;642-646.
35. Varghese J. N., Epa V. C., Colman P. M. Three-dimensional structure of the complex of 4-guanidino-Neu5Ac2en and influenza virus neuraminidase. Protein Sci. 4:1995;1081-1087.
36. Varghese J. N., Laver W. G., Colman P. M. Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution. Nature (London). 303:1983;35-40.
37. von Itzstein M., Wu W.-Y., Kok G. B., Pegg M. S., Dyason J. C., Jin B., Phan T. V., Smythe M. L., White H. F., Oliver S. W., Colman P. M., Varghese J. N., Ryan D. M., Woods J. M., Bethell R. C., Hotham V. J., Cameron J. M., Penn C. R. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature (London). 363:1993;418-423.
38. Warner T. G., O'Brien J. S. Synthesis of 2′-(4-methylumbelliferyl)-α-DN. Biochemistry. 18:1979;2783-2787.
39. Woods J. M., Bethell R. C., Coates J. A. V., Healy N., Hiscox S. A., Pearson B. A., Ryan D. M., Ticehurst J., Tilling J., Walcott S. M., Penn C. R. 4-Guanidino-2,4-dideoxy-2,3-dehydro-N. Antimicrob. Agents Chemother. 37:1993;1473-1479.